Stentrode is the only implantable brain-computer interface that does not require open brain surgery and is currently in clinical trials SAN FRANCISCO & NEW YORK & MELBOURNE, Australia--(BUSINESS WIRE) ...
Neuralink, Synchron, and Neuracle are expanding clinical trials and trying to zero in on an actual product. Tech companies are always trying out new ways for people to interact with computers—consider ...
NEW YORK--(BUSINESS WIRE)--Synchron, a brain computer interface (BCI) company, today announced the results from a study in which four people with ALS received an implant of Synchron’s Stentrode™ ...
Please provide your email address to receive an email when new articles are posted on . The Stentrode brain-computer interface offers a non-invasive, nonsurgical solution for paralysis. Additional ...
The brain-computer interface developer Synchron has shown that its minimally invasive device can help connect a patient with an iPad, allowing them to control the device entirely by thought using ...
Synchron, a New York, NY-based manufacturer of non-surgical brain-computer interface technology, said it has raised a $200 million series D round. The funds are expected to accelerate ...
Rodney Gorham recently passed a milestone that few people have reached. He’s had a brain-computer interface implanted for five years. Made by startup Synchron, the experimental implant allows him to ...
Synchron has reeled in another $200 million in a series D round—cash the company said it will use to expand operations and accelerate commercialization of its nonsurgical brain-computer interface (BCI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results